What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

Journal of Neurology Neurosurgery and Psychiatry

Volumn 68, Issue 4, 2000, Pages 434-440

  Wenning, G K ^a   Ben Shlomo, Y ^b   Hughes, A ^c   Daniel, S E ^d   Lees, A ^d   Quinn, N P ^e  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c AUSTIN HEALTH   (Australia)

^d Institute of Neurology   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Clinicopathological study; Differential diagnosis; Multiple system atrophy; Parkinson's disease

Indexed keywords

LEVODOPA;

AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FALLING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR CONTROL; MULTIVARIATE ANALYSIS; MUSCLE RIGIDITY; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SHY DRAGER SYNDROME; SPEECH DISORDER;

EID: 0034066538     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.68.4.434     Document Type: Article

References (37)

1. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(suppl):78-89.
2. Dejerine J, Thomas A. L'atrophie olivo-ponto-cérébelleuse. Nouvelle Iconographie de la Salpêtrière 1900;13:330-70.
3. Adams RD, van Bogaert L, van der Eecken. Dégénérescences nigro-striées et cérébello-nigro-striées. Psychiatria et Neurologica (Basel) 1961;142:219-59.
4. Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension. Arch Neurol 1960;2:511-27.
5. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34
6. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS in patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
7. Papp M, Lantos P. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992;107:172-82
8. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-43.
9. Wenning GK, Ben-Shlomo Y, Magalhães M, et al. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-6.
10. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937-44.
11. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-42.
12. Quinn NP, Marsden CD. The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 1993;56: 1239-42.
13. Wenning GK, Ben-Shlomo Y, Magalhães M, et al. The clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-45.
14. Quinn N. Parkinsonism: recognition and differential diagnosis. BMJ 1995;310:447-52
15. Ben-Shlomo Y, Wenning GK, Tison F, et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997;48:384-93.
16. Albanese A, Colosimo C, Bentivoglio AR, et al. Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;59:144-51.
17. Colosimo C, Albanese A, Hughes AJ, et al. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-8.
18. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992a;55:181-4.
19. Hughes AJ, Ben Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42: 1142-6.
20. Hughes AJ, Colosimo C, Kleedorfer B, et al. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992c;55:1009-13.
21. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-8.
22. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-47.
23. Gray F, Vincent D, Hauw JJ. Quantitative study of lateral horn cells in 15 cases of multiple system atrophy. Acta Neuropathol 1988;75:513-18.
24. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. London: Butterworth-Heinemann, 1994:262-81.
25. Wenning GK, Quinn N, Magalhães M, et al. Minimal change multiple system atrophy. Mov Disord 1994;9:161-6.
26. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Mathias C, Bannister R, eds. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system, 3rd ed. Oxford: Oxford University Press, 1999:564-85.
27. Mark MH, Sage JI, Dickson DW, et al. Levodopanonresponsive Lewy body parkinsonism: clinicopathologic study of two cases. Neurology 1992;42:1323-7.
28. Wagner ML, Fedak MN, Sage JI, et al. Complications of disease and therapy: a comparison of younger and older patients with Parkinson's disease. Ann Clin Lab Sci 1996;26:389-95.
29. Mayeux R, Danaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992;49:492-7.
30. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
31. Spokes EGS, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure. Clinical, histological and neurochemical observations in four cases. J Neurol Sci 1070;43:59-82.
32. Kluin KJ, Gilman S, Lohman M, et al. Characteristics of the dysarthria of multiple system atrophy. Arch Neurol 1996;53: 545-8.
33. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-20.
34. Magalhães M, Wenning GK, Daniel SE, et al. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease: a retrospective comparison. Acta Neurol Scand 1995;91:98-102.
35. Oppenheimer DR. Lateral horn cells in progressive autonomie failure. J. Neurol Sci 1980;46:393-404.
36. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-58.
37. Polinsky RJ. Multiple system atrophy: clinical aspects, pathophysiology and treatment. In: Jankovic J, ed. Neurologic clinics. Vol 2. Philadelphia: Saunders 1984:487-98.